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A B S T R A C T
Ovalbumin (OVA) sensitization has limitations in modelling asthma. Thus, we examined the value of allergic
sensitization using a puriﬁed natural allergen, house dust mite (HDM), over the sensitization performed with
OVA. Mice were sham-treated, or sensitized with OVA- or HDM with identical chronology. Airway resistance,
tissue damping and elastance were assessed under control conditions and after challenging the animals with
methacholine (MCh) and the speciﬁc allergen. Inﬂammatory proﬁle of the bronchoalveolar lavage ﬂuid was
characterized and lung histology was performed. While no diﬀerence in the lung responsiveness to the speciﬁc
allergen was noted, hyperresponsiveness to MCh was observed only in the HDM-sensitized animals in the lung
peripheral parameters. Lung inﬂammation diﬀered between the models, but excessive bronchial smooth muscle
remodelling occurred only with OVA. In conclusion, we demonstrate that a puriﬁed natural allergen oﬀers a
more relevant murine model of human allergic asthma by expressing the key features of this chronic in-
ﬂammatory disease both in the lung function and structure.
1. Introduction
Increasing exposure to environmental allergens and pollution con-
tribute to the dramatic rise in the incidence of chronic lung diseases
such as asthma, which is a major public health concern (ELF, 2009;
WHO, 2008). One of the main features of asthma is chronic airway
inﬂammation with subsequent bronchial hyperresponsiveness to dif-
ferent stimuli (Bosse, 2014; Brutsche et al., 2006; Mannino and Buist,
2007). Various animal models contributed greatly to a better under-
standing of the underlying pathophysiological mechanisms and to the
characterization of the complex interactions between allergic, neuro-
logic and immunological pathways (Gern, 2008).
In the last decades, airway sensitization to ovalbumin (OVA) was
considered as the experimental model of reference to investigate the
pathogenesis of allergic lung diseases (Bayat et al., 2009; Habre et al.,
2008). However, the value of OVA in these models to mimic human
asthma has been challenged due to the lack of key mechanisms such as
eosinophil migration, sustained chronic airway inﬂammation and the
development of allergen tolerance leading to desensitization
(DiGiovanni et al., 2009; Fattouh et al., 2005; Johnson et al., 2004;
Swirski et al., 2002). Another important limitation of OVA exposure is
related to the site of lung mechanical response. This is limited to the
central conducting airways after an exposure to a nonspeciﬁc con-
strictor stimuli, such as methacholine or histamine (Bayat et al., 2009),
despite the involvement of small airways in the lung function dete-
riorations during asthma exacerbations (Bjermer, 2014; Contoli et al.,
2012).
Recently, there has been an increased interest towards using natural
airborne allergens in the animal models of allergic respiratory diseases.
Among them, dermatophagoides pteronissinus (D. pter) is the most
widespread dust mite with Der p1 being one of the major proteins
implicated in the allergic process induced by D. Pter (Tournoy et al.,
2000; Tovey et al., 1981). It has been identiﬁed as having a cysteine
protease activity capable of inducing epithelial desquamation, in-
ﬂammatory cytokines release and allergens transport facilitation
(Kauﬀman et al., 2006). It stimulates pulmonary inﬂammation, IgE
humoral response (Gough et al., 2003; Kikuchi et al., 2006) and Th2
cell response (Comoy et al., 1998). Therefore, sensitization to house
dust mite (HDM) appears the most clinically relevant asthma model in
mice and is gaining interest in experimental research (Kikuchi et al.,
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2006). However, to date, the contribution of the conducting airways
and the lung periphery to the lung mechanical responses following
exogenous constrictor stimuli have not been compared between murine
models of OVA and HDM sensitization. Additionally, such character-
ization is still missing following provocation with the speciﬁc allergen,
which is of clinical relevance since asthma exacerbation occurs essen-
tially following repeated airborne allergen exposures.
Therefore, we aimed at comparing the responses in the central
conducting airways as well as in the lung periphery between mice
sensitized and exposed to OVA with those sensitized and exposed to Der
p1. Moreover, we aimed at investigating the diﬀerences between the 2
sensitization regimens following a lung constriction induced by non-
speciﬁc cholinergic stimuli and during the early phase of allergic re-
sponse.
2. Materials and methods
2.1. Animals
All experiments and procedures were conducted under the approval
from the Swiss animal welfare committee (Geneva Cantonal Veterinary
Oﬃce, registration number 1043/3924/2). Forty-four 10 week-old
(22.0 ± 0.2 g) female BALB/cAnNRj mice purchased from Janvier
Labs (St Berthevin, France) were involved in the study. Female BALB/c
mice were chosen because of the most susceptible gender and strains to
respiratory allergies including for HDM and OVA (Berndt et al., 2011;
Blacquiere et al., 2010; Leme et al., 2010; Melgert et al., 2005).
2.2. Sensitization to allergens
Lyophilized total protein extracts of D. pter with known concentra-
tion of Der p1 were obtained from Stallergenes (Antony, France).
Lyophilized ovalbumin from chicken egg white was purchased from
SigmaAldrich (Buchs, Swizerland). Both substances were suspended in
normal saline. Mice were sensitized to HDM with a protocol adapted
from Tourdot et al. (2011). For an appropriate comparison, sensitiza-
tions with OVA and HDM were performed according to the same
chronology. For both allergens, the procedure was initiated with two
intraperitoneal injections of OVA (50 μg/200 μL) or HDM (dose
equivalent to 10 μg Der p1 conveyed in 200 μL) supplemented with Al
(OH)3 as an adjuvant (2 mg) (Fig. 1A). 30-min long aerosol exposures to
the allergens were then performed between days 21–25 with OVA
(1 mg/mL) and HDM (dose equivalent to 0.1 mg/mL of Der p1), re-
spectively. The same injections and aerosol exposures were carried out
for the control group of mice with normal saline (SAL).
2.3. Anaesthesia and surgical preparation
Mice were anesthetized on day 28 or 29 with 5% isoﬂurane in a box
until reﬂexes disappeared. Then a subcutaneous injection of a mixture
of metomidate (Syndel Laboratories Ltd., Canada; 60 mg/kg) and fen-
tanyl (60 μg/kg) was administered. After 5 min, a local anaesthesia by
subcutaneous injection of 0.5% xylocaine (0.5 mL) was provided and a
tracheostomy was performed. Mice were tracheotomised and me-
chanically ventilated with Flexivent system (Emka Technologies, Falls
Church, VA, USA) in volume- controlled mode (tidal volume 8 mL/kg,
180 breaths/min, I:E 1/1.5, positive end-expiratory pressure (PEEP) 3
cmH2O, FiO2 50%). The mice were paralyzed thereafter with an in-
traperitoneal injection of muscle relaxant (5 mg/kg rocuronium bro-
mide) to inhibit spontaneous breathing movements. This injection was
repeated as needed (onset of respiratory movements during measure-
ments). Similarly, the anaesthesia was maintained by additional in-
traperitoneal boluses of the anaesthetics at half doses of the con-
centrations used for the induction. Body temperature was maintained
between 38 and 39 °C by using a heating mat and controlled rectally by
a thermal sensor. ECG was continuously monitored by means of needle
electrodes and PowerLab data acquisition system (ADinstrument,
Dunedin, New Zealand).
2.4. Challenges and protocol groups
Mice were assigned into one or the other of the 7 protocol groups
(Fig. 1B). Respiratory function was assessed in the anesthetized and
ventilated animals by using the Flexivent system. In the mice chal-
lenged with the allergens, measurements were made during the base-
line conditions and for 30 min following a single challenge of aero-
solized OVA (1 mg/mL for 40s) in the Groups SAL/OVA (n = 6) and
OVA/OVA (n = 8) or D. pter (0.1 mg/mL for 40 s) in the Groups SAL/
HDM (n = 5) and HDM/HDM (n = 7). Measurements were made each
30 s until 2 min, then each 1 min for the following 3 min, every 2 min
until 15 min followed by 20 and 30 min recording. In the other mice
enrolled in groups SAL/MCh (n = 6), OVA/MCh (n = 8) and HDM/
MCh (n = 6), basal respiratory mechanical measurements were re-
peated during an aerosolized challenge with a non-speciﬁc cholinergic
constrictor agonist, methacholine (MCh) administered at increasing
dose of 0.78, 1.56, 3.125, 6.25, 12.5 mg/mL (for 10 s each).
2.5. Measurement of respiratory mechanics
Lung volume history was standardized while inspiratory capacity
(IC) was measured during the ﬁrst deep inﬂation manoeuvre (slow in-
ﬂation from PEEP to 30 cm H2O with 3 s breath hold). Forced oscilla-
tory respiratory mechanics were measured with Flexivent system.
Respiratory system input impedance (Zrs) was derived from the signals
detected by the ventilator piston volume displacement and cylinder
pressure during 8 s oscillatory volume perturbations with 17 prime
frequencies ranging from 0.5 and to 19.75 Hz. The impedance data
were ﬁtted with a model comprising an airway resistance (Raw) and
inertance in series with a constant-phase model incorporating tissue
damping (G) and elastance (H) (Hantos et al., 1992). Respiratory tissue
hysteresivity (η) was calculated as G/H (Fredberg and Stamenovic,
1989).
2.6. Assessment of lung inﬂammation
At the end of the experiment, the animal was disconnected from the
ventilator. Pre-warmed (38 °C) PBS was instilled via the endotracheal
tube with a syringe containing a volume of 30 μL/g body weight (total
lung volume of BALB/c mice (Thiesse, 2009)). Three gentle wash-in and
wash-out maneuvers were made with the syringe to collect the broncho-
alveolar lavage ﬂuid (BALF); thereafter the animal was immediately
euthanized. The BALF was centrifuged at 2000 rpm for 5 min at 5 °C
and supernatant sampled and stored at−20 °C until use. The cell pellet
was resuspended in BSA 1% in PBS, further dropped onto slides and
centrifuged at 750 rpm for 7 min by cytospin. Then slides were ﬁxed
and stained with May Grünwald Giemsa for diﬀerential cell counting.
Then stained slides were scanned by Mirax and the cells were counted
by using an image acquisition software (Panoramic viewer, 3DHISTECH
Ltd, Budapest, Hungary). Since the distribution of the cells was in-
homogeneous, the cells were counted within rectangles with an edge
length equivalent to the radius of the circular cytospin. The number of
cells was normalized to the surface area of the rectangles.
2.7. Cytokine essays
The BALF supernatant and the blood serum were used to assess
inﬂammatory cytokines. Blood samples were centrifuged at 4500 rpm
for 3 min to collect serum, which was diluted 4× before the assays.
Immuno assay with an appropriate software (Bio-Plex Manager™
Multiplex Reader) was used to measure ﬂuorescence in the multiplex kit
(Bio-Plex Pro™ Mouse Cytokine Th1/Th2 Assay #M6000003J7). This
kit allowed the measurement of eight mice cytokines GM-CSF, IFN-γ, IL-
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2, IL-4, IL-5, IL-10, IL-12 (p70), TNF-α).
2.8. Lung histology
At the end of the experiment, the lungs were excised, rinsed with
PBS and ﬁlled with 4% formaldehyde under a pressure of 20 cmH2O.
The ﬁxed lungs were embedded into paraﬃn wax and 10 μm sections
were made, mounted on slides and stained with haematoxylin and eosin
to determine cellular inﬁltrates.
5 μm thick lung tissue sections were made from the formalin-ﬁxed,
paraﬃn-embedded lung tissues and were analysed by im-
munohistochemistry using anti-alpha-smooth muscle actin (αSMA,
anti-AML, Dako, #M0851, 70 mg/mL) with the Ventana Discovery
automated staining system (Ventana Medical Systems, Tucson, AZ,
USA). For anti-alpha smooth muscle actin antibodies, no antigen re-
trieval pre-treatment was required. After automatic deparaﬃnization,
slides were incubated 30 min at 37 °C with primary antibodies diluted
at 1/300 in antibody solution from Dako Schweiz GmbH (Switzerland,
ref. S2022). Then secondary antibodies were applied at dilution 1/250
(anti-mouse IgG1 + IgG2a + IgG3, abcam, ab133469, 2.03 mg/mL).
Detection of secondary antibodies was carried out using the rabbit
OmniMap kit (Ventana Medical Systems, Tucson, AZ, USA), based on
conversion of diaminobenzidine to a dye with multimeric horseradish
peroxidase.
The paraﬃn-embedded lung tissue sections were also stained with
Masson trichrome (Sigma-Aldrich®, Switzerland) to determine the re-
lative proportion of sub-epithelial collagen deposition. These sections
were analysed by using the Developer XD2 image analysis software
(Deﬁniens AG, Munich, Germany).
2.9. Statistical analyses
Considering the variability in the primary outcome, Raw, and based
on our previous experiment with similar methodology (Petak et al.,
2001), the study was planned in order to detect at least 40% diﬀerence
between groups by using 80% power. Standard errors of the means
(SEM) are reported. Normal distribution was veriﬁed with the Shapiro-
Wilk test. In case of lack of normality, logarithmic transformation was
performed before applying parametric tests. The grouped data of BALF
and respiratory mechanics were tested with two-way analyses of var-
iances (ANOVA) with Holm-Sidak post-hoc tests. Total cell counts in the
BALF, IC, histological and cytokine data were evaluated by using one-
way ANOVA tests. The statistical tests were performed with SigmaPlot
(Version 12.5, Systat Software, Inc.) and Prism (version 6, GraphPad
Software Inc.).
3. Results
3.1. Basal respiratory mechanical parameters
Table 1 summarizes the absolute values of the airway and
Fig. 1. A: Scheme of the sensitization procedure. B:
summary of the protocol groups exposed chronically
to diﬀerent allergens challenged acutely with a non-
speciﬁc constrictor stimulus (methacholine) or to the
speciﬁc allergen (ovalbumin or house dust mite).
Table 1
Baseline values (mean ± SEM) of respiratory mechanical parameters in the protocol
groups including mice exposed to an allergen (SAL/OVA, OVA/OVA, SAL/HDM and




G (cmH2O/mL) H (cmH2O/mL) η
SAL/OVA 0.23 ± 0.01 4.18 ± 0.10 15.56 ± 0.22 0.25 ± 0.01
OVA/OVA 0.26 ± 0.01 4.03 ± 0.15 16.58 ± 0.50 0.25 ± 0.01
SAL/HDM 0.26 ± 0.02 3.74 ± 0.07 15.05 ± 0.50 0.24 ± 0.01
HDM/HDM 0.29 ± 0.02 3.83 ± 0.11 16.53 ± 0.69 0.27 ± 0.00
SAL/MCh 0.28 ± 0.03 3.66 ± 0.10 14.51 ± 0.58 0.24 ± 0.01
OVA/MCh 0.25 ± 0.02 3.99 ± 0.08 15.88 ± 0.48 0.25 ± 0.00
HDM/MCh 0.30 ± 0.01 3.83 ± 0.13 16.35 ± 0.75 0.23 ± 0.01
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respiratory tissue parameters under the baseline conditions. No statis-
tically signiﬁcant diﬀerences were detected in any of these variables
between the protocol groups. The IC exhibited signiﬁcant decreases in
mice sensitized with both OVA (0.867 ± 0.02 mL, p < 0.001) and
HDM (0.951 ± 0.02 mL, p < 0.01), as compared to control animals
(1.06 ± 0.03 mL).
3.2. Lung responses to the speciﬁc allergens
Fig. 2 displays on the left panels the time course of the airway and
respiratory tissue parameters following challenges with the speciﬁc
allergens. The group means of the peak responses obtained in each
individual mouse are also demonstrated on the right panels. Immediate
increases in Raw were observed in both groups of sensitized mice
(p < 0.05), which were sustained throughout the 30-min study period.
Parameters reﬂecting the lung peripheral changes exhibited similar
changes with marked diﬀerences in the temporal dynamics: OVA
challenge led to delayed elevations in G (p < 0.001) and H
(p < 0.001), whereas HDM resulted in immediate responses in these
indices (p < 0.001 for both).
In accordance with these time courses, the peak airway responses in
the HDM- and OVA-exposed animals were manifested in signiﬁcant
increases following the allergen exposure (p < 0.05 for both) when
compared to the non-sensitized controls. Similarly, both allergens in-
creased G and H signiﬁcantly with peak elevations being greater in the
allergen-sensitized mice than their corresponding controls (p < 0.01
and p < 0.02). The proportional increases in G and H resulted in a
constant η in mice challenged with OVA or HDM, with no signiﬁcant
Fig. 2. Left panels depict the temporal changes
(mean ± SEM) in the airway (airway resistance:
Raw) and tissue mechanics (tissue damping: G, tissue
elastance: H), while right panels show the group
mean of the peak responses (mean ± SEM) fol-
lowing exposures to the speciﬁc allergens ovalbumin
(OVA) or house dust mite (HDM). SAL/OVA (n = 6):
sham-sensitized mice exposed to OVA, OVA/OVA
(n = 8): OVA-sensitized mice exposed to OVA, SAL/
HDM (n = 5): sham-sensitized mice exposed to
HDM, HDM/HDM (n = 7): HDM-sensitized mice
exposed to HDM. *: p < 0.05 vs. baseline (BL)
within a group, #: p < 0.05 OVA/OVA vs. HDM/
HDM, $: p < 0.05 SAL/OVA vs. OVA/OVA, +:
p < 0.05 SAL/HDM vs. HDM/HDM, §: p < 0.05
between peak responses (Two-way repeated mea-
sures ANOVA).
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diﬀerence between the protocol groups.
3.3. Lung responsiveness to a nonspeciﬁc cholinergic challenge
Fig. 3 depicts the dose response curves for the respiratory me-
chanical parameters following administrations of increasing doses of an
aerosolized nonspeciﬁc constrictor agonist, MCh. The allergen sensi-
tized groups responded diﬀerently to MCh. While there was no evidence
for a diﬀerence between the OVA/MCh and the control SAL/MCh
groups in Raw, G and H, HDM-sensitized mice exhibited exaggerated
responses in Raw compared to those receiving OVA (p < 0.05).
Moreover, MCh induced signiﬁcantly greater responses in the para-
meters G and H in the HDM-sensitized mice compared to OVA-sensi-
tized and to control mice (p < 0.02 and p < 0.05, respectively). The
excessive increases in G over those on H were reﬂected in the elevated η
in the HDM exposed mice following administration of the highest dose
of MCh (p < 0.01).
3.4. Lung inﬂammation
Fig. 4 shows the total leucocytes count in the bronchoalveolar la-
vage ﬂuid and the relative proportion of the inﬂammatory cell com-
ponents. The total amount of inﬂammatory cells was signiﬁcantly ele-
vated in the OVA and HDM sensitized mice relative to their controls
(p < 0.001 and p < 0.01, respectively). While macrophages were
consistently dominant in all control groups, eosinophil inﬂux was de-
tected in both sensitized groups, with a more apparent eosinophilia in
the HDM/HDM group (p < 0.001). These changes were associated
with signiﬁcant decreases in the relative proportion of macrophages in
the OVA/OVA and HDM/HDM groups compared to their corresponding
controls (p < 0.001 for both).
3.5. BALF cytokine proﬁle
The cytokine concentrations in the BALF supernatant are shown in
Fig. 5. The allergen sensitization with OVA and HDM led to marked
diﬀerences in the BALF cytokine production. OVA sensitization induced
changes in the BALF cytokine proﬁle with increased IL-4 (p < 0.03),
and decreased IL-2 (p < 0.03), IL-10 (p < 0.03), IL-12 (p < 0.001)
and GM-CSF (p < 0.001), and no detectable change in IL-5 and IFN-γ.
Sensitization with HDM signiﬁcantly increased secretion of IL-4
(p < 0.001), and decreased release of IL-2 (p < 0.02), IL-12
(p < 0.001) GM-CSF (p < 0.001) and TNF-α (p < 0.001), with no
detectable change in IL-5, IL-10 and IFN-γ. Compared to the OVA
group, BALF from HDM-sensitized mice contained higher concentra-
tions of IL-4 (p < 0.03) IL-10 (p < 0.05) and IF-γ (p < 0.05).
3.6. Histological evaluation
Fig. 6 summarizes the histological ﬁndings in the animals included
in the protocol groups. Epithelial thickness was signiﬁcantly elevated in
both groups of mice sensitized with OVA and HDM (p < 0.001 for
both). Over-expression of α-SMA positive cells was detected in both
sensitized groups (p < 0.001 and p < 0.05 for OVA and HDM, re-
spectively) with a signiﬁcantly higher over-expression in the mice
sensitized with OVA (p < 0.001). Conversely, sub-epithelial collagen
deposition was signiﬁcantly enhanced in the HDM group both in
comparison with the control mice (p < 0.05) and those sensitized with
OVA (p < 0.001).
4. Discussion
The results of the present study revealed fundamental diﬀerences
between two diﬀerent models of allergen sensitization using a natural
allergen extract (OVA) and a puriﬁed natural allergen (HDM). Hyper
responsiveness to a cholinergic non-speciﬁc constrictor stimulus and
Fig. 3. Dose response curves (mean ± SEM) in airway resistance (Raw),
tissue damping (G), tissue elastance (H) and hysteresivity (η) to aero-
solized methacholine (MCh) in sham-sensitized mice (SAL/MCh, n = 6)
and in mice sensitized with ovalbumin (OVA/MCh, n = 8) or house dust
mite (HDM/MCh, n = 6). *: p < 0.05 vs. baseline (BL) within a group, #:
p < 0.05 between OVA/MCh and HDM/MCh (Two-way repeated mea-
sures ANOVA).
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alterations in the BALF cellular and cytokine proﬁles observed in the
HDM model appeared more relevant to the human asthma phenotype.
Conversely, both models exhibited similar airway and tissue respon-
siveness to the speciﬁc allergen. Histological investigations evidenced
comparable epithelial thickening, with increased bronchial smooth
muscle remodelling in OVA-sensitized mice as reﬂected by the over-
expression of αSMA antibodies.
4.1. Lung responsiveness to a nonspeciﬁc cholinergic challenge
In an attempt to characterize the bronchial hyperreactivity fol-
lowing OVA and HDM sensitization, the mice were challenged with
incremental doses of inhaled methacholine. This cholinergic stimula-
tion led to a parallel increase in Raw in all groups of animals with no
evidence for a diﬀerence as compared with the saline exposed mice.
The mechanism contributing to this ﬁnding may be related to the po-
tential contamination of the commercial allergens with lipopoly-
saccharide, which has been shown to blunt murine immunologic re-
sponses and prohibits the development of BHR (Watanabe et al., 2003).
However, comparing OVA- and HDM-sensitized mice revealed sig-
niﬁcantly greater central airway responses to MCh in the latter model.
As the lung peripheral responses are concerned, a clear-cut ﬁnding
was observed in the lung tissue parameters with a signiﬁcant response
in the mice sensitized with HDM. These results, along with signiﬁcant
decrease in IC, suggest that the eosinophilic inﬂammation following
HDM exposure is localized preferably in the parenchyma rather than in
the central airways (Layachi et al., 2013). Interestingly, the hyster-
esivity; G/H, increased dose-dependently during methacholine chal-
lenge, which suggests that the alteration of tissue resistance following
MCh-induced constriction is also due to increased airway in-
homogeneity (Lutchen et al., 1996). The primary involvement of the
lung periphery following MCh challenges agree with the results of
previous studies in HDM-sensitized mice (Li et al., 2014; Phan et al.,
2016).
The development of BHR following OVA-sensitization is a subject of
controversy with some papers demonstrating airway hyperresponsive-
ness to a non-speciﬁc constrictor challenge (Barlow et al., 2011;
Kaufman et al., 2011; Wang et al., 2011), while others failed to detect
increased airway narrowing following a similar sensitization regimen
with OVA (Bates et al., 2008; Card et al., 2010; Yiamouyiannis et al.,
1999). One possible explanation for these conﬂicting results is the po-
tential desensitization of the airways following repeated OVA exposures
(DiGiovanni et al., 2009; Fattouh et al., 2005; Ruiz Schutz et al., 2009;
Swirski et al., 2002; Yiamouyiannis et al., 1999). The existence of this
potential tolerance to chronic exposure to OVA can be anticipated from
the altered cytokine proﬁle in OVA-sensitized mice. The tendency for a
decrease in IL-5 and IL-10, along with lower eosinophilia and lack of
BHR strongly suggest progression towards a tolerance process. These
ﬁndings indicate essential diﬀerences in the airway smooth muscle
responsiveness to a cholinergic challenge, with better suitability of the
HDM model to investigate this important feature of human asthma.
4.2. Lung responses to the speciﬁc allergens
Despite the frequent investigations of OVA, assessment for airways
and tissue mechanics following puriﬁed natural allergen (such as HDM)
remains scarce (Li et al., 2014), and is limited to a short time follow-up
in the sub-acute phase (< 3 min). In the present study we extended the
observation windows to characterize airway and respiratory tissue
mechanical responses to 30 min. The results revealed remarkable dif-
ferences in the temporal dynamics of the peripheral lung responses
between mice exposed to OVA and those sensitized with HDM, dete-
riorations of tissue mechanics starting as early as 30 s in the former,
whereas only after 5 min in the latter case.
While the reason for this ﬁnding is not completely clear, the distinct
lung inﬂammatory proﬁle may explain the diﬀerences between the two
Fig. 4. Total number of leukocytes in the bronchoalveolar lavage ﬂuid
(top) and the relative diﬀerential cell counts for the mice enrolled in the
protocol groups. SAL/OVA (n = 6): sham-sensitized mice exposed to OVA,
OVA/OVA (n = 8): OVA-sensitized mice exposed to OVA, SAL/HDM
(n = 5): sham-sensitized mice exposed to HDM, HDM/HDM (n = 7):
HDM-sensitized mice exposed to HDM. *: p < 0.05 vs. the corresponding
sham-sensitized (Two-way ANOVA).
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sensitization modes. The proportionally greater inﬂux of eosinophils
and neutrophils in the BALF (Fig. 4), with increased speciﬁc allergic
inﬂammatory cytokines IL-4 and IL-10, as well as reduced anti-in-
ﬂammatory cytokines IL-2 and IL-12 in HDM indicates more intense
inﬂammatory response in the peripheral airways (Fig. 5) (Tourdot
et al., 2011). This inﬂammatory proﬁle may have contributed to a rapid
and sustained mast cell degranulation in the HDM-sensitized mice.
Since η remained constant, as G and H changed together, we can hy-
pothesize that allergen exposure led to either changes in the intrinsic
viscoelastic properties of the lung parenchyma, and/or a uniform clo-
sure of a terminal alveolar unit due to the uneven deposition of the
constrictor agonist.
As concerns the lack of increase in TNF-α in the sensitized animals,
the timing of the experiments from the allergen challenge may have
played a role, since the concentration of this cytokine has been shown
to decline rapidly by 24 h after the allergen exposure (Kim et al., 2006).
Thus, TNF-α may have been at the nadir level by the time of our ex-
periment, which was performed 72 h after the allergen exposure, while
IL-4 were still overexpressed. Moreover, the reason for the lack of in-
crease in GM-CSF may be explained by the dependency of its expression
by the clinical subtype (Kuo et al., 2017). It is also possible that in the
current models, the decreased concentration of macrophages in the
sensitized groups may have further contributed to the diminished GM-
CSF protein concentration measured in the BALF.
4.3. Allergic asthma models: OVA versus HDM
In the present study, the sensitization procedure followed similar
chronological administration with the 2 allergens. Previous reports
highlighted the importance of protocol designs both in their chronology
and dose of administration, for the development of a model of bronchial
hyperreactivity (Chang et al., 2005; Petak et al., 2010). The discrepancy
between OVA and HDM seems to be related to the nature of the allergen
itself or to the repeated administration, which may have led to de-
sensitization as discussed above (Swirski et al., 2002; Yeh et al., 2015).
However, we cannot rule out that these two allergens may have dif-
ferent sensitization procedures required to reach their optimal eﬀect.
The involvement of time and regularity of allergen exposure requires
further investigations.
The diﬀerence between the two allergen models was also revealed
in an earlier study following chronic intranasal OVA or HDM exposure
with the same chronology in BALB/c mice (Johnson et al., 2004). A
diﬀerence in the respiratory patterns, assessed by unrestrained body
plethysmography, between HDM-sensitized and OVA-exposed mice was
associated with the presence of lung inﬂammation only in the HDM-
sensitized group.
Applying diﬀerent optimized protocols for sensitization with OVA
and HDM also demonstrated that the latter was more eﬃcient in in-
ducing an experimental model of asthma (DiGiovanni et al., 2009). In
Fig. 5. Cytokine concentrations in the bronchoalveolar lavage ﬂuid in sham-sensitized
mice (C, n = 6) and in mice sensitized with ovalbumin (OVA, n = 8) or house dust mite
(HDM, n = 7). *: p < 0.05 between protocol groups (one-way ANOVA).
Fig. 6. Epithelial thickness (top left), thickness of smooth muscle contractile elements
(αSMA, top right), and relative amount of sub-epithelial collagen (bottom) in sham-
sensitized mice (C, samples based on n = 6) and in mice sensitized with ovalbumin (OVA,
samples based on n = 8) or house dust mite (HDM, samples based on n = 7). *: p < 0.05
between protocol groups (one-way ANOVA).
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line with our ﬁndings, the use of HDM was more eﬀective in inducing
lung inﬂammation and increase reactivity to MCh which was not re-
lated to overexpression of contractile smooth muscle cells but rather to
a Th2/Th1 imbalance (DiGiovanni et al., 2009; Li et al., 2014; Piyadasa
et al., 2016). Moreover, mice sensitized with HDM were the only one
that exhibited pro-ﬁbrotic lung tissue remodelling, which is a hallmark
of asthma (Locke et al., 2007). This ﬁnding agrees with previous results
demonstrating the importance of the combination of airway in-
ﬂammation, sub-epithelial ﬁbrosis and airway hyperresponsiveness in
the pathogenesis of asthma (Royce et al., 2014). This structural im-
pairment is in line with the excessive increases observed in the lung
function parameters reﬂecting the lung periphery (G and H).
4.4. Summary and conclusions
The present study related lung mechanical responses to cholinergic
and allergen stimuli, the inﬂammatory proﬁle and airway remodelling
in murine models of asthma. Our ﬁndings revealed that sensitization
with HDM led to a more speciﬁc airway inﬂammation expressed in the
augmentation of eosinophils and a Th1/Th2 imbalance. This in-
ﬂammatory response was associated with enhanced lung peripheral
response to a non-speciﬁc cholinergic constrictor stimulus, which was
not expressed in the animals sensitized with OVA. These results de-
monstrate that sensitization with a puriﬁed natural allergen oﬀers a
more relevant murine model of human allergic asthma and can be
suitable for characterizing diﬀerent intervention strategies to prevent or
treat allergen-induced lung constriction.
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